The discovery and optimization of benzimidazoles as selective NaV1.8 blockers for the treatment of pain

Add time:07/14/2019    Source:sciencedirect.com

The voltage gated sodium channel NaV1.8 has been postulated to play a key role in the transmission of pain signals. Core hopping from our previously reported phenylimidazole leads has allowed the identification of a novel series of benzimidazole NaV1.8 blockers. Subsequent optimization allowed the identification of compound 9, PF-06305591, as a potent, highly selective blocker with an excellent preclinical in vitro ADME and safety profile.

We also recommend Trading Suppliers and Manufacturers of 1H-benzimidazole-pentane-2-amine (cas 39650-63-0). Pls Click Website Link as below: cas 39650-63-0 suppliers

Prev:Optimization and biological evaluation of 2-aminobenzothiazole derivatives as Aurora B kinase inhibitors
Next:Synthesis of optically active trifluoromethyl-substituted 2,3-dihydroimidazo[2,1-b]oxazoles)